Filing Flows › Rapid Micro Biosystems (RPID) › Q4 2025
Rapid Micro Biosystems (RPID) Q4 2025 earnings results (fourth quarter 2025)
10-K filed Mar 12, 2026
Rapid Micro Biosystems (RPID) reported revenue of $11.3M for the fourth quarter 2025 (Q4 2025), +37% from a year earlier and +44% from the quarter before. Operating margin was -108.2%, net loss $12.5M (110.8% of revenue).
Rapid Micro Biosystems, Q4 2025: revenue $11.3M (+37% year over year), operating margin -108.2%, net loss $12.5M, operating cash flow −$3.2M. The chart follows the revenue to costs, profit and cash.
| Q4 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $11.3M | +44% | +37% |
| Operating profit | −$12.2M | — | — |
| Net earnings | −$12.5M | — | — |
| Operating cash flow | −$3.2M | — | — |
What changed
Revenue was $11.3M in Q4 2025, up 37% year over year and up 44% from the previous quarter. Product was the largest line at 83% of revenue.
Operating costs exceeded revenue by $12.2M, an operating margin of -108.2%. Total costs grew 27% against revenue growth of 37%. The fastest-growing cost line was Other operating costs (+60%). The quarter ended with a net loss of $12.5M, wider than the previous quarter's $11.5M loss.
Operating cash flow was −$3.2M. Non-cash charges added back $790K of depreciation and amortization and $627K of share-based compensation. Working capital and other items added $7.8M. Capital expenditures of $92K exceeded it, leaving free cash flow of −$3.3M.
Questions
What was Rapid Micro Biosystems' revenue in the fourth quarter 2025?
Rapid Micro Biosystems (RPID) reported revenue of $11.3M for the fourth quarter 2025 (Q4 2025), +37% from a year earlier and +44% from the quarter before.
Was Rapid Micro Biosystems profitable in the fourth quarter 2025?
Operating loss was $12.2M (-108.2% of revenue) and net loss $12.5M.